Literature DB >> 7628063

Endocrine and carbohydrate responses to interleukin-6 in vivo.

R D Stith1, J Luo.   

Abstract

The role of interleukin-6 (IL-6) in carbohydrate metabolism beyond its inhibition of hepatic phosphoenolpyruvate carboxykinase has not been widely pursued. To describe such IL-6 effects, we examined in the rat the responses of plasma corticosterone, glucagon, insulin, and glucose levels and the hepatic glycogen content 30, 60, 90, 120, and 180 min after intravenous injection of recombinant human IL-6. The effect to increase plasma corticosterone was consonant with the well-known action of IL-6 on the hypothalamus-pituitary-adrenal cortex. IL-6 produced a transient increase in plasma glucagon that was mirrored by elevated plasma glucose and a depletion of hepatic glycogen. Plasma insulin levels were not elevated within the first hour after IL-6 injection but were significantly elevated 90 min and beyond. We suggest that the stimulus for increased circulating insulin was elevated plasma glucose, rather than a direct effect of IL-6. The results demonstrate that IL-6, acting directly on peripheral organs and/or through the central nervous system (CNS) can alter the hormonal and carbohydrate milieu. We propose that these actions of IL-6 are one aspect of its role in the acute phase response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7628063

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  12 in total

Review 1.  Regulation of adipocytokines and insulin resistance.

Authors:  M Fasshauer; R Paschke
Journal:  Diabetologia       Date:  2003-11-06       Impact factor: 10.122

Review 2.  Interleukin-6 and insulin sensitivity: friend or foe?

Authors:  A L Carey; M A Febbraio
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

3.  Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models.

Authors:  Y D Kim; Y H Kim; Y M Cho; D K Kim; S W Ahn; J M Lee; D Chanda; M Shong; C H Lee; H S Choi
Journal:  Diabetologia       Date:  2012-02-21       Impact factor: 10.122

4.  C-reactive protein -717C>T genetic polymorphism associates with esophagectomy-induced stress hyperglycemia.

Authors:  Satoru Motoyama; Masatomo Miura; Yudai Hinai; Kiyotomi Maruyama; Katsuyuki Murata; Jun-Ichi Ogawa
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

5.  Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans.

Authors:  R L Starkie; M J Arkinstall; I Koukoulas; J A Hawley; M A Febbraio
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

6.  Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes.

Authors:  Y H Hamid; C S Rose; S A Urhammer; C Glümer; R Nolsøe; O P Kristiansen; T Mandrup-Poulsen; K Borch-Johnsen; T Jorgensen; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2005-01-11       Impact factor: 10.122

Review 7.  The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis.

Authors:  Hannah E Young; Wendy E Ward
Journal:  Reprod Sci       Date:  2020-09-10       Impact factor: 3.060

8.  Interleukin-6, soluble interleukin-6 receptor/interleukin-6 complex and insulin resistance in obese children and adolescents.

Authors:  G De Filippo; D Rendina; F Moccia; V Rocco; A Campanozzi
Journal:  J Endocrinol Invest       Date:  2014-09-23       Impact factor: 4.256

Review 9.  Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis.

Authors:  Lars Hecht; Ralph Möhler; Gabriele Meyer
Journal:  Ger Med Sci       Date:  2011-08-08

10.  Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions.

Authors:  Michael Lehrke; Uli C Broedl; Ingeborg M Biller-Friedmann; Michael Vogeser; Volkmar Henschel; Kirsten Nassau; Burkhard Göke; Erich Kilger; Klaus G Parhofer
Journal:  Crit Care       Date:  2008-12-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.